Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-7jkgd Total loading time: 0 Render date: 2025-02-25T19:49:37.905Z Has data issue: false hasContentIssue false

4 - Genetic Susceptibility to Visceral Leishmaniasis

Published online by Cambridge University Press:  02 December 2019

By
Hiba S. Mohamed ,
Muntaser E. Ibrahim  and
Jenefer M. Blackwell
Edited by
Muntaser E. Ibrahim  and
Charles N. Rotimi
Muntaser E. Ibrahim
Affiliation:
University of Khartoum
Charles N. Rotimi
Affiliation:
National Human Genome Research Institute/NIH
Get access

Summary

The leishmaniases are a group of related diseases caused by parasites of the genus Leishmania (Order Kinetoplastidae, family Trypansomatidae). The clinical presentations of leishmaniasis include visceral leishmaniasis (VL) or kala-azar, post-kala-azar dermal leishmaniasis (PKDL), localized cutaneous leishmaniasis (LCL), disseminated cutaneous leishmaniasis (DCL), and mucosal leishmaniasis (ML). These different clinical patterns of infection are principally related to the species of Leishmania. All species of Leishmania are transmitted by sand flies; Phlebotomus spp. in the Old World and Lutzomyia longipalpis in the New World. Humans, wild animals, and domestic animals are known to act as reservoir hosts. Visceral leishmaniasis is associated with infection by members of the L. donovani species complex, including L. donovani sensu strictu, L. infantum, and L. aethiopica, and is characterized by fever, weight loss, epistaxis, pancytopenia, anorexia, abdominal pain, cough, diarrhea, nausea and vomiting, weakness, fatigue, splenomegaly, hepatomegaly, and lymphadenopathy. Other clinical signs of VL can include edema, neurological changes, and, less frequently, psychosis and jaundice (Zijlstra and el-Hassan 2001b). As well as being a severe systemic infection, a proportion of patients treated for VL go on to present with cutaneous disease, termed PKDL (Zijlstra and el-Hassan 2001a; Zijlstra et al. 1994). Recent analysis by the WHO estimates that 200,000–400,000 new cases occur annually, 90 percent of which are in India, Bangladesh, Sudan, South Sudan, Ethiopia, and Brazil (Alvar et al. 2012). In Africa, the highest incidence rate was reported in the East African region, with estimated annual incidence of 29,400–56,700. The reported VL cases per year in the region is 8560, of which Sudan, South Sudan, and Ethiopia have the highest incidence rates, in that order. A small number of cases have been reported from Somalia, Uganda, Kenya, and Eritrea. Visceral leishmaniasis is also present in other foci in Africa, such as Morocco, Algeria, and Tunisia, with estimated annual incidence rate of 300, 130, and 110 cases, respectively (Alvar et al. 2012).

Type
Chapter
Information
The Genetics of African Populations in Health and Disease , pp. 71 - 85
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alvar, J, Velez, ID, Bern, C, et al. (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671.CrossRefGoogle ScholarPubMed
Amsen, D, Blander, JM, Lee, GR, et al. (2004). Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117: 515–526.Google Scholar
Badaro, R, Jones, TC, Lorenco, R, et al. (1986). A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154: 639–649.CrossRefGoogle Scholar
Barral-Netto, M, Badaro, R, Barral, A, et al. (1991). Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 163: 853–857.Google Scholar
Blackwell, JM (1996). Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112: S67-S74.Google Scholar
Blackwell, JM, Freeman, J, Bradley, D (1980). Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 283: 72–74.Google Scholar
Blackwell, JM, Barton, CH, White, JK, et al. (1994). Genetic regulation of leishmanial and mycobacterial infections: The Lsh/Ity/Bcg gene story continues. Immunol Lett 43: 99–107.CrossRefGoogle ScholarPubMed
Blackwell, JM, Goswami, T, Evans, CAW, et al. (2001). SLC11A1 (formerly NRAMP1) and disease. Cell Microbiol 3: 773–784.Google Scholar
Blackwell, JM, Searle, S, Mohamed, H, and White, JK (2003). Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol Lett 85: 197–203.Google Scholar
Blackwell, JM, Fakiola, M, Ibrahim, ME, et al. (2009). Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol 31: 254–266.CrossRefGoogle ScholarPubMed
Bradley, DJ (1974). Genetic control of natural resistance to Leishmania donovani. Nature 250: 353–354.CrossRefGoogle ScholarPubMed
Bradley, DJ (1977). Regulation of Leishmania populations within the host: II. Genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin Exp Immunol 30: 130–140.Google Scholar
Bradley, DJ (1979). Regulation of Leishmania populations within the host: IV. Parasite and host cell kinetics studied by radioisotope labelling. Acta Trop 36: 171–179.Google Scholar
Bucheton, B, Kheir, MM, El-Safi, SH, et al. (2002). The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 4: 1449–1457.Google Scholar
Bucheton, B, Abel, L, El-Safi, S, et al. (2003a). A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet 73: 1052–1060.Google Scholar
Bucheton, B, Abel, L, Kheir, MM, et al. (2003b). Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun 4: 104–109.CrossRefGoogle Scholar
Bucheton, B, Argiro, L, Chevillard, C, et al. (2007). Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun 8: 79–83.CrossRefGoogle ScholarPubMed
Cabello, PH, Lima, AM, Azevedo, ES, and Kriger, H (1995). Familial aggregation of Leishmania chagasi infection in northeastern Brazil. Am J Trop Med Hyg 52: 364–365.Google Scholar
Carvalho, EM, Barral, A, Pedral-Sampaio, D, et al. (1992). Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis 165: 535–540.Google Scholar
Castellucci, L, Jamieson, SE, Miller, EN, et al. (2010). CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case–control and family-based study. BMC Med Genet 11: 10.CrossRefGoogle Scholar
Clayton, D (1999). A generalization of the transmission disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65: 1170–1177.Google Scholar
Dudbridge, F and Gusnanto, A (2008). Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32: 227–234.Google Scholar
Faghiri, Z, Tabei, SZ, Taheri, F (1995). Study of the association of HLA class I antigens with kala-azar. Hum Hered 45: 258–261.CrossRefGoogle ScholarPubMed
Fakiola, M, Mishra, A, Rai, M, et al. (2010). Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis. PLoS One 5: e15807.Google Scholar
Fakiola, M, Miller, EN, Fadl, M, et al. (2011). Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. J Infect Dis 204: 467–477.CrossRefGoogle ScholarPubMed
Fakiola, M, Strange, A, Cordell, HJ, et al. (2013). Common variants in the HLA–DRB1–HLA–DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 45: 208–213.Google ScholarPubMed
Feitosa, MF, Axevedo, E, Lima, AM, and Krieger, H (1999). Genetic causes involved in Leishmania chagasi infection in northeastern Brazil. Genet Mol Biol 22: 1–5.Google Scholar
Frade, AF, Oliveira, LC, Costa, DL, et al. (2011). TGFB1 and IL8 gene polymorphisms and susceptibility to visceral leishmaniasis. Infect Genet Evol 11: 912–916.Google Scholar
Gautam, S, Kumar, R, Maurya, R, et al. (2011). IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 204: 1134–1137.Google Scholar
Goswami, T, Bhattacharjee, A, Babal, P, et al. (2001). Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J 354: 511–519.CrossRefGoogle Scholar
Gros, P, Skamene, E, and Forget, A (1981). Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127: 2417–2421.Google Scholar
Hindorff, LA, Junkins, HA, Mehta, JP, and Manolio, TA (2009). A catalog of published genome-wide association studies. Available at: www.ebi.ac.uk/gwas (accessed February 10, 2016).Google Scholar
Ho, M, Siongok, TK, Lyerly, WH, and Smith, DH (1982). Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg 76: 741–746.Google Scholar
Ibrahim, ME, Lambson, B, Yousif, AO, et al. (1999). Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 61: 941–944.Google Scholar
Jabado, N, Jankowski, A, Dougaparsad, S, et al. (2000). Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 192: 1237–1248.CrossRefGoogle ScholarPubMed
Jamieson, SE, Miller, EN, Peacock, CS, et al. (2007). Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun 8: 84–90.Google Scholar
Jeronimo, SM, Oliveira, RM, Mackay, S, et al. (1994). An urban outbreak of visceral leishmaniasis in Natal. Brazil Trans R Soc Trop Med Hyg 88: 386–388.Google Scholar
Jeronimo, SM, Duggal, P, Braz, RF, et al. (2004). An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil. Scand J Infect Dis 36: 443–449.Google Scholar
Jeronimo, SM, Duggal, P, Ettinger, N, et al. (2007a). Genetic predisposition to symptomatic versus self-curing infection with the protozoan Leishmania chagasi: a genome wide scan. J Infect Dis 196: 1261–1269.CrossRefGoogle Scholar
Jeronimo, SM, Holst, AK, Jamieson, SE, et al. (2007b). Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun 8: 539–551.Google Scholar
Karplus, TM, Jeronimo, SM, Chang, H, et al. (2002). Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 70: 6919–6925.Google Scholar
Kemp, M, Kurtzhals, JA, Kharazmi, A, and Theander, TG (1993). Interferon-gamma and interleukin-4 in human Leishmania donovani infections. Immunol Cell Biol 71: 583–587.Google Scholar
Khalil, EA, Zijlstra, EE, Kager, PA, and El, Hassan AM (2002). Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health 7: 35–44.Google Scholar
Kumar, R, Singh, N, Gautam, S, et al. (2014). Leishmania specific CD4 T cells release IFNgamma that limits parasite replication in patients with visceral leishmaniasis. PLoS Negl Trop Dis 8: e3198.Google Scholar
Lander, E and Kruglyak, L (1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241–247.Google Scholar
Locksley, RM and Scott, P (1991). Helper T-cell subsets in mouse leishmaniasis induction, expansion and effector function. Immunol Today 12: A58–A61.CrossRefGoogle ScholarPubMed
Maekawa, Y, Tsukumo, S, Chiba, S, et al. (2003). Delta1–Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 19: 549–559.Google Scholar
Meddeb-Garnaoui, A, Gritli, S, Garbouj, S, et al. (2001). Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to Mediterranean visceral leishmaniasis. Hum Immunol 62: 509–517.Google Scholar
Mehrotra, S, Oommen, J, Mishra, A, et al. (2011). No evidence for association between SLC11A1 and visceral leishmaniasis in India. BMC Med Genet 12: 71.Google Scholar
Mehrotra, S, Fakiola, M, Mishra, A, et al. (2012). Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India. Infect Genet Evol 12: 1195–1201.Google Scholar
Miller, EN, Fadl, M, Mohamed, HS, et al. (2007). Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 that control visceral leishmaniasis in The Sudan. PLoS Genet 3: 679–688.Google Scholar
Mock, B, Blackwell, J, Hilgers, J, Potter, M, and Nacy, C (1993). Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur J Immunogenet 20: 335–348.Google Scholar
Mohamed, H (2002). Genetic susceptibility to visceral leishmaniasis in Sudan. PhD Thesis, University of Khartoum.Google Scholar
Mohamed, HS, Ibrahim, ME, Miller, EN, et al. (2003). Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun 4: 351–355.Google Scholar
Mohamed, HS, Ibrahim, ME, Miller, EN, et al. (2004). SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet 12: 66–74.Google Scholar
Moravej, A, Rasouli, M, Kalani, M, et al. (2012). IL-1beta (-511T/C) gene polymorphism not IL-1beta (+3953T/C) and LT-alpha (+252A/G) gene variants confers susceptibility to visceral leishmaniasis. Mol Biol Reports 39: 6907–6914.Google Scholar
Murray, HW, Rubin, BY, and Rothermel, CD (1983). Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes: evidence that interferon-gamma is the activating lymphokine. J Clin Invest 72: 1506–1510.Google Scholar
Nylen, S and Sacks, D (2007). Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28: 378–384.Google Scholar
Nylen, S, Maurya, R, Eidsmo, L, et al. (2007). Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805–817.Google Scholar
Ong, CT, Sedy, JR, Murphy, KM, and Kopan, R (2008). Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS One 3: e2823.Google Scholar
Peacock, CS, Collins, A, Shaw, MA, et al. (2001). Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol 20: 383–396.Google Scholar
Peacock, CS, Sanjeevi, CB, Shaw, MA, et al. (2002). Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: no major role for class II or class III regions of HLA. Genes Immun 3: 350–358.Google Scholar
Pirmez, C, Yamamura, M, Uyemura, K, Paes-Oliveira, M, and Modlin, RL (1993). Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91: 1390–1395.Google Scholar
Plant, J and Glynn, AA (1974). Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice. Nature 248: 345–347.Google Scholar
Plant, J and Glynn, AA (1976). Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 133: 72–78.Google Scholar
Plant, J and Glynn, AA (1979). Locating salmonella resistance gene on mouse Chromosome 1. Clin Exp Immunol 37: 1–6.Google Scholar
Plant, JE, Blackwell, JM, O’Brien, AD, Bradley, DJ, and Glynn, AA (1982). Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature 297: 510–511.Google Scholar
Roberts, M, Mock, BA, and Blackwell, JM (1993). Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur J Immunogenet 20: 349–362.CrossRefGoogle ScholarPubMed
Salih, MA, Ibrahim, ME, Blackwell, JM, et al. (2007). IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun 8: 75–78.Google Scholar
Scott, P, Pearce, E, Cheever, AW, Coffman, RL, and Sher, A (1989). Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 112: 162–182.CrossRefGoogle ScholarPubMed
Shaw, MA, Davies, CR, Llanos-Cuentas, EA, and Collins, A (1995). Human genetic susceptibility and infection with Leishmania peruviana. Am J Hum Genet 57: 1159–1168.Google Scholar
Singh, N, Sundar, S, Williams, F, et al. (1997). Molecular typing of HLA class I and class II antigens in Indian kala-azar patients. Trop Med Int Health 2: 468–471.Google Scholar
Singh, OP, Gidwani, K, Kumar, R, et al. (2012a). Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol 19: 961–966.Google Scholar
Singh, OP, Stober, CB, Singh, AK, Blackwell, JM, and Sundar, S (2012b). Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl Trop Dis 6: e1874.Google Scholar
Skamene, E (1994). The Bcg gene story. Immunobiology 191: 451–460.Google Scholar
Skamene, E, Gros, P, Forget, A, et al. (1982). Genetic regulation of resistance to intracellular pathogens. Nature 297: 506–509.Google Scholar
Sundar, S, Reed, SG, Sharma, S, Mehrotra, A, and Murray, HW (1997). Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 56: 522–525.Google Scholar
Vidal, SM, Malo, D, Vogan, K, Skamene, E, and Gros, P (1993). Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469–485.Google Scholar
Zijlstra, EE and el-Hassan, AM (2001a). Leishmaniasis in Sudan: post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 95(Suppl. 1): S59–S76.Google Scholar
Zijlstra, EE and el-Hassan, AM (2001b). Leishmaniasis in Sudan: visceral leishmaniasis. Trans R Soc Trop Med Hyg 95(Suppl. 1): S27–S58.Google Scholar
Zijlstra, EE, el-Hassan, AM, Ismael, A, and Ghalib, HW (1994). Endemic kala-azar in Eastern Sudan, a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51: 826–836.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×